This content is machine translated B-cell lymphomas Bispecific antibodies – mechanisms, evidence and future role Bispecific antibodies represent an important therapeutic advance in the treatment of aggressive B-cell lymphomas. Through the targeted recruitment of T cells against malignant B cells, they open up new options...…
View Post 2 min This content is machine translated Study report: Primary cutaneous lymphomas Skin-directed or systemic therapy? Diffuse large B-cell lymphoma is the most common malignant tumor of the lymphatic system. The primary objective of a retrospective clinical study led by Charité-Universitätsmedizin Berlin was to compare systemic…
